-
ArticlePublication 2016Blog: The Opioid Abuse Crisis is a Rare Area of Bipartisan Consensus
The U.S. is experiencing political polarization over many issues, including health. There are few examples …
The U.S. is experiencing political polarization over many issues, including health. There are few examples where Democrats and Republicans in Congress, as well as those among the public who identify with the two parties, agree on a set of policies. One of these exceptions involves policies to address the opioid abuse crisis facing the country today. Public opinion polls conducted in 2015 and 2016 examine this unusual bipartisan consensus. The two obvious questions are (1)…
Chronic Disease/Risk | Mental Health | Social Determinants | Policy/Regulation | Government/Law | Health/Medicine | North America -
Online LearningWeb Portal, Teaching Resource 2018Course: The Opioid Crisis in America
This self-paced online course from HarvardX challenges preconceptions about addiction and about who can become …
This self-paced online course from HarvardX challenges preconceptions about addiction and about who can become addicted to opioids, which are part of a drug class that includes heroin as well as pain relievers such as oxycodone, hydrocodone, morphine, codeine, fentanyl, and others. Students learn about the origins and spread of opioid use, misuse, and addiction. The course covers the appropriate ways in which prescription opioid drugs can be used to treat specific pain conditions, and…
Preferences/Values | Health Outcomes | Chronic Disease/Risk | Mental Health | Social Determinants | Policy/Regulation | Economics/Finance | Government/Law | Health/Medicine | North America | College | Graduate | Doctoral | Professional | Critical Thinking/Analysis | Decision Making/Leadership | Policy Translation -
ArticlePublication 2017How ACA Repeal Would Worsen the Opioid Epidemic
As the U.S. Surgeon General’s recent report on addiction highlights, the United States faces a …
As the U.S. Surgeon General’s recent report on addiction highlights, the United States faces a serious opioid epidemic that shows no signs of abating. The rate of death due to opioid-related overdose has increased by more than 200% over the past 15 years, and we are now losing more Americans to overdose deaths each year than we did to AIDS during the peak of that epidemic. The authors of this editorial argue that an effective…
Priority Setting/Ethics | Health Outcomes | Chronic Disease/Risk | Mental Health | Health Systems | Policy/Regulation | Economics/Finance | Government/Law | Health/Medicine | North America -
DataPublication 2017Surveillance Report of Drug-Related Risks and Outcomes - U.S.
This report summarizes the latest information available for various health outcomes, health behaviors, and prescribing …
This report summarizes the latest information available for various health outcomes, health behaviors, and prescribing patterns related to the drug problem in the United States. This report covers latest data available on rates of opioid prescribing, substance use disorder, nonfatal hospitalizations and emergency department visits, and overdose deaths. National information, and some state information, is presented to serve as a resource to help address the ongoing national problem of drug abuse, addiction, and overdose. Also…
Health Outcomes | Chronic Disease/Risk | Mental Health | Social Determinants | Health/Medicine | North America -
DataInteractive 2020Data Interactive: U.S. Opioid Prescribing Rates
The data in the maps show the geographic distribution in the United States, at both …
The data in the maps show the geographic distribution in the United States, at both state and county levels, of retail opioid prescriptions dispensed per 100 persons from 2006-2020. Data are displayed within two types of interactive maps that show the estimated rate of opioid prescriptions per 100 U.S. residents. The state maps portray these rates for each of the 50 states plus the District of Columbia. Users can hover over a county or state…
Chronic Disease/Risk | Mental Health | Health Systems | Policy/Regulation | Economics/Finance | Health/Medicine | North America -
ReportPublication 2015Opioid Dependence: Final Report
This report from the Institute for Clinical and Economic Review (ICER) examines the comparative effectiveness and value …
This report from the Institute for Clinical and Economic Review (ICER) examines the comparative effectiveness and value of interventions for the management of opioid dependence. The goals of the report are to document the federal and New England state regulations affecting treatment options, provide an overview of existing clinical guidelines and payer coverage policies, and summarize the evidence on the different management approaches for opioid dependence, including special considerations for adolescents. An appendix is provided by ICER.…
Preferences/Values | Health Outcomes | Evidence Synthesis | Cost-Effectiveness Analysis | Technology Assessment | Chronic Disease/Risk | Mental Health | Health Systems | Policy/Regulation | Business/Industry | Government/Law | Health/Medicine | Science/Technology | North America -
ReviewPublication 2017Quality of Life as an Outcome of Opioid Use Disorder Treatment
The recent opioid epidemic has prompted renewed interest in opioid use disorder treatment, but there …
The recent opioid epidemic has prompted renewed interest in opioid use disorder treatment, but there is little evidence regarding health-related quality-of-life (HRQoL) outcomes in treatment programs. Measuring HRQoL represents an opportunity to consider outcomes of opioid use disorder treatment that are more patient-centered and more relevant to overall health than abstinence alone. This systematic literature review explores the extent to which the collection of HRQoL by opioid treatment programs is documented in the treatment program literature.…
Preferences/Values | Health Outcomes | Evidence Synthesis | Chronic Disease/Risk | Mental Health | Social Determinants | Health Systems | Economics/Finance | Health/Medicine -
ArticlePublication 2016Measuring Benefits of Opioid Misuse Treatment: HRQOL of Opioid-Dependent Individuals and Spouses
This study sought to understand how the general public views the quality of life effects …
This study sought to understand how the general public views the quality of life effects of opioid misuse and opioid use disorder on an individual and his/her spouse, measured in terms used in economic evaluations. The study design was a cross-sectional internet survey of a US population-representative respondent panel conducted December 2013-January 2014, with a total of 2054 randomly selected adults, of whom 51.1% were male. The mean individual utility ranged from 0.574 for active injection…
Preferences/Values | Health Outcomes | Chronic Disease/Risk | Mental Health | Economics/Finance | Health/Medicine | North America -
ArticlePublication 2017Joint Utility Estimators in Substance Use Disorders
Although co-occurring conditions are common with substance use disorders, estimation methods for joint health state …
Although co-occurring conditions are common with substance use disorders, estimation methods for joint health state utilities have not yet been tested in this context. The objective of this paper was to compare joint health state utility estimators in substance use disorders to inform economic evaluation. The authors conducted two Internet-based surveys of US adults to collect community perspective standard gamble utilities for substance use disorders and common co-occurring conditions. They evaluated six conditions as they occur individually…
Preferences/Values | Evidence Synthesis | Chronic Disease/Risk | Mental Health | Health/Medicine | North America -
ArticlePublication 2015Short Term HRQoL Improvement during Opioid Agonist Treatment
Opioid dependence is associated with high levels of morbidity, yet sparse data exists regarding the …
Opioid dependence is associated with high levels of morbidity, yet sparse data exists regarding the health-related quality of life (HRQoL) of individuals with opioid dependence, particularly following treatment initiation. To inform cost-effectiveness analyses of treatment modalities, this study investigates short-term changes in HRQoL following enrollment into opioid agonist treatment, across treatment modalities and patient subgroups. Data was analyzed from the Starting Treatment with Agonist Replacement Therapies (START) and Prescription Opioid Addiction Treatment Studies (POATS) randomized…
Preferences/Values | Health Outcomes | Chronic Disease/Risk | Mental Health | Health/Medicine | North America -
Online LearningVideo, Teaching Resource 2017Forum. The Opioid Crisis: A Governors Roundtable
Opioid overdoses claim the lives of 91 Americans every day, according to the Centers for …
Opioid overdoses claim the lives of 91 Americans every day, according to the Centers for Disease Control and Prevention. This Forum - The Opioid Crisis: A Governors Roundtable, is part of the series, Policy Controversies, and was presented jointly with PRI’s The World & WGBH News. In this multimedia forum, four former governors offered candid insights into how government policy can help, exploring what works and what doesn’t. They spoke about experiences within their own…
Priority Setting/Ethics | Health Outcomes | Chronic Disease/Risk | Mental Health | Social Determinants | Health Systems | Policy/Regulation | Economics/Finance | Government/Law | Health/Medicine | North America | College | Graduate | Doctoral | Professional | Critical Thinking/Analysis | Decision Making/Leadership | Policy Translation -
ArticlePublication 2013Cost-Effectiveness of Injectable Opioid vs. Oral Methadone for Chronic Heroin Addiction
Despite evidence of the effectiveness of injectable opioid treatment compared with oral methadone for chronic …
Despite evidence of the effectiveness of injectable opioid treatment compared with oral methadone for chronic heroin addiction, the additional cost of injectable treatment is considerable, and cost-effectiveness uncertain. This analysis compares the cost-effectiveness of supervised injectable heroin and injectable methadone with optimized oral methadone for chronic refractory heroin addiction using data from a multisite, open-label, randomized controlled trial. Outcomes were assessed in terms of quality-adjusted life-years (QALYs). The economic perspective included health, social services and criminal…
Preferences/Values | Costing Methods | Cost-Effectiveness Analysis | Chronic Disease/Risk | Mental Health | Health Systems | Policy/Regulation | Economics/Finance | Government/Law | Health/Medicine | Europe -
ReportPublication 2017Economic Value of Informal Mental Health Caring
Caregivers, family and friends play a significant role in supporting people with mental illness, and …
Caregivers, family and friends play a significant role in supporting people with mental illness, and it has long been recognized that informal carers constitute a significant ‘hidden’ workforce in Australia. Faced as Australia is with an ageing population and burgeoning chronic disease, data on the contribution that carers make and the consequent savings to governments and other ‘payers’ need to be articulated. This report attempts to put a ‘value’ on informal caring for those with mental illness.…
Preferences/Values | Costing Methods | Health Outcomes | Benefit-Cost Analysis | Cost-Effectiveness Analysis | Chronic Disease/Risk | Mental Health | Health Systems | Economics/Finance | Health/Medicine | Oceania -
ReportPublication 2017Underestimated Cost of the Opioid Crisis
This report on the opioid public health crisis was released by the White House Council …
This report on the opioid public health crisis was released by the White House Council on Economic Advisors (CEA) in November 2017. It corrects previous estimates of related costs by adding the value of the associated deaths. Earlier estimates focused on medical and other expenditures, while the new report also includes estimates of the value that individuals place on reducing their own risks of premature mortality. The report notes that, in 2015, over 33,000 Americans…
Preferences/Values | Costing Methods | Benefit-Cost Analysis | Chronic Disease/Risk | Mental Health | Policy/Regulation | Economics/Finance | Government/Law | Health/Medicine | North America -
ReportPublication 2017World Drug Report 2017
The World Drug Report 2017 is produced by the United Nations Office on Drugs and …
The World Drug Report 2017 is produced by the United Nations Office on Drugs and Crime in a five-booklet format. Booklet 1 summarizes the content of the four subsequent substantive booklets and presents policy implications drawn from their findings. Booklet 2 deals with the supply, use and health consequences of drugs. Booklet 3 focuses on the cultivation, production and consumption of the three plant-based drugs (cocaine, opiates and cannabis) and on the impact of new…
Health Outcomes | Chronic Disease/Risk | Mental Health | Policy/Regulation | Global Governance | Economics/Finance | Government/Law | Health/Medicine | Science/Technology | Global -
ArticlePublication 2017Cost-Effectiveness of ED-Initiated Treatment for Opioid Dependence
In a recent randomized trial, patients with opioid dependence receiving brief intervention, emergency department (ED)-initiated …
In a recent randomized trial, patients with opioid dependence receiving brief intervention, emergency department (ED)-initiated buprenorphine and ongoing follow-up in primary care with buprenorphine (buprenorphine) were twice as likely to be engaged in addiction treatment compared with referral to community-based treatment (referral) or brief intervention and referral (brief intervention). This study evaluates the relative cost-effectiveness of these three methods of intervening on opioid dependence in the ED. Measured health-care use was converted to dollar values. The…
Costing Methods | Health Outcomes | Cost-Effectiveness Analysis | Chronic Disease/Risk | Mental Health | Health Systems | Policy/Regulation | Economics/Finance | Government/Law | Health/Medicine | North America -
ReportPublication 2016Cost-Effectiveness of Mental, Neurological, and Substance Use Disorders
This report chapter reviews the available cost-effectiveness evidence for the different levels and underpinning strategies of …
This report chapter reviews the available cost-effectiveness evidence for the different levels and underpinning strategies of the mental health care system, with a focus on information generated in or for lower and middle income countries. First, the chapter reviews the economic evidence for mental health prevention and protection at the population and community levels of the health and welfare system, including legislative, regulatory, and informational measures at the public policy level (population platform), as well as…
Evidence Synthesis | Cost-Effectiveness Analysis | Chronic Disease/Risk | Health Systems | Health/Medicine | Global -
Lesson/ModuleWeb Portal, Teaching Resource 2017NY Times: Investigating the Heroin and Prescription Opioid Epidemic
This lesson plan produced by The New York Times focuses on the heroin and prescription …
This lesson plan produced by The New York Times focuses on the heroin and prescription opioid epidemics in the United States. Focusing on statistics, social issues, and health, the lesson plan offers discussion questions, activities, and resources for further learning.
Preferences/Values | Health Outcomes | Chronic Disease/Risk | Mental Health | Health Systems | Policy/Regulation | Government/Law | Health/Medicine | North America | High School | College | Critical Thinking/Analysis | Graphics/Visualization -
DataWeb Portal 2017CDC Data Portal: Drug Overdose Deaths and Opioid-Involved Deaths
This data portal hosted by the Centers for Disease Control and Prevention depicts how drug …
This data portal hosted by the Centers for Disease Control and Prevention depicts how drug overdose deaths and opioid-involved deaths continue to increase in the United States. Deaths from drug overdose are up among both men and women, all races, and adults of nearly all ages. More than three out of five drug overdose deaths involve an opioid. Opioids are substances that work on the nervous system in the body or specific receptors in the…
Health Outcomes | Chronic Disease/Risk | Mental Health | Health/Medicine | North America -
ReportPublication 2016DCP3: Mental, Neurological, and Substance Use Disorders
This report from the World Bank is the fourth volume of the Disease Control Priorities, …
This report from the World Bank is the fourth volume of the Disease Control Priorities, Third Edition (DCP3) series. It discusses the prevalence of mental, neurological, and substance use disorders, as well as the associated disability and premature mortality that can accompany them. Despite the high social and economic burden of these diseases on individuals, families, and communities, these disorders have been systematically neglected, especially in low- and middle-income countries, and there has been limited…
Costing Methods | Health Outcomes | Evidence Synthesis | Cost-Effectiveness Analysis | Mental Health | Health Systems | Global Governance | Economics/Finance | Health/Medicine | Global
20 Shown
Teaching Resources
Collections
Learner Level
Teaching Resources
Collections
Learner Level